Subtopic Deep Dive
Takayasu Arteritis
Research Guide
What is Takayasu Arteritis?
Takayasu arteritis is a chronic granulomatous large-vessel vasculitis primarily affecting the aorta and its major branches in young patients, leading to stenosis, occlusion, or aneurysm formation.
Takayasu arteritis predominantly occurs in women under 40 years old and causes vascular inflammation with high morbidity if untreated (Özen et al., 2010; 1383 citations). Research focuses on classification criteria, imaging modalities like FDG-PET/CT and MRI, and management guidelines including glucocorticoids and biologics (Hellmich et al., 2019; 1098 citations; Dejaco et al., 2018; 941 citations). Over 10 key EULAR and ACR guidelines and cohort studies shape current understanding.
Why It Matters
Takayasu arteritis leads to disabling complications like stroke, hypertension, and heart failure in young patients, with guarded prognosis despite therapy as shown in a US cohort with frequent relapses (Maksimowicz-McKinnon et al., 2007; 502 citations). EULAR recommendations guide glucocorticoid tapering and anti-TNF use in refractory cases, reducing vascular damage progression (Hellmich et al., 2019; 1098 citations; Hoffman et al., 2004; 421 citations). Imaging protocols using FDG-PET/CT enable early diagnosis and monitoring, improving outcomes in clinical practice (Dejaco et al., 2018; 941 citations; Slart et al., 2018; 461 citations).
Key Research Challenges
Relapse and Disease Progression
Patients experience frequent relapses and irreversible vascular stenosis despite immunosuppressive therapy. A US cohort showed limited remission rates and ongoing progression (Maksimowicz-McKinnon et al., 2007; 502 citations). Long-term prognosis remains guarded with high morbidity.
Optimal Biologic Therapy Selection
Refractory cases require anti-TNF agents, but response varies and guidelines evolve. Hoffman et al. (2004; 421 citations) demonstrated benefits in difficult-to-treat patients. Selecting between TNF inhibitors and tocilizumab remains unresolved.
Standardized Imaging Protocols
FDG-PET/CT and MRI aid diagnosis but lack unified scoring for activity assessment. EULAR recommends multimodal imaging, yet procedural standardization is needed (Dejaco et al., 2018; 941 citations; Slart et al., 2018; 461 citations).
Essential Papers
EULAR/PRINTO/PRES criteria for Henoch–Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria
Seza Özen, Angela Pistorio, S. M. Iusan et al. · 2010 · Annals of the Rheumatic Diseases · 1.4K citations
2018 Update of the EULAR recommendations for the management of large vessel vasculitis
Bernhard Hellmich, Ana Águeda, Sara Monti et al. · 2019 · Annals of the Rheumatic Diseases · 1.1K citations
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice
Christian Dejaco, Sofía Ramiro, Christina Duftner et al. · 2018 · Annals of the Rheumatic Diseases · 941 citations
To develop evidence-based recommendations for the use of imaging modalities in primary large vessel vasculitis (LVV) including giant cell arteritis (GCA) and Takayasu arteritis (TAK). European Leag...
EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides
Seza Özen, N Ruperto, M J Dillon et al. · 2005 · Annals of the Rheumatic Diseases · 831 citations
EULAR recommendations for the management of large vessel vasculitis
Chetan Mukhtyar, Loı̈c Guillevin, María C. Cid et al. · 2008 · Annals of the Rheumatic Diseases · 665 citations
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis
Mehrdad Maz, Sharon A. Chung, Andy Abril et al. · 2021 · Arthritis & Rheumatology · 564 citations
Objective To provide evidence‐based recommendations and expert guidance for the management of giant cell arteritis (GCA) and Takayasu arteritis (TAK) as exemplars of large vessel vasculitis. Method...
Limitations of therapy and a guarded prognosis in an american cohort of takayasu arteritis patients
Kathleen Maksimowicz‐McKinnon, Tiffany Clark, Gary S. Hoffman · 2007 · Arthritis & Rheumatism · 502 citations
Abstract Objective To describe the clinical, laboratory, and radiographic manifestations of Takayasu arteritis (TA) in a cohort from the US, evaluate the response to interventions, remission and re...
Reading Guide
Foundational Papers
Start with Özen et al. (2010; 1383 citations) for classification criteria and Mukhtyar et al. (2008; 665 citations) for early management recommendations, as they establish diagnostic and therapeutic baselines cited in all subsequent guidelines.
Recent Advances
Study Hellmich et al. (2019; 1098 citations) for updated EULAR management and Maz et al. (2021; 564 citations) for ACR guidelines integrating biologics and imaging.
Core Methods
Core techniques include FDG-PET/CT for activity assessment (Slart et al., 2018; Dejaco et al., 2018), MRI for vessel wall imaging (Meller et al., 2003), and anti-TNF therapy for refractory disease (Hoffman et al., 2004).
How PapersFlow Helps You Research Takayasu Arteritis
Discover & Search
Research Agent uses searchPapers and exaSearch to find EULAR guidelines like Hellmich et al. (2019; 1098 citations) on large vessel vasculitis management, then citationGraph reveals connected pediatric criteria by Özen et al. (2010; 1383 citations) and findSimilarPapers uncovers imaging studies such as Dejaco et al. (2018).
Analyze & Verify
Analysis Agent employs readPaperContent on Özen et al. (2010) classification criteria, verifies guideline concordance via verifyResponse (CoVe), and runs PythonAnalysis to meta-analyze GRADE evidence levels across EULAR recommendations (Hellmich et al., 2019) for statistical remission rates in Takayasu cohorts.
Synthesize & Write
Synthesis Agent detects gaps in biologic therapy evidence between Hoffman et al. (2004) and recent ACR guidelines (Maz et al., 2021), flags contradictions in imaging utility, then Writing Agent uses latexEditText, latexSyncCitations for guideline comparisons, and latexCompile to generate formatted review manuscripts with exportMermaid vascular progression diagrams.
Use Cases
"Extract and plot remission rates from Takayasu arteritis cohort studies."
Research Agent → searchPapers('Takayasu arteritis cohorts') → Analysis Agent → readPaperContent(Maksimowicz-McKinnon 2007) + runPythonAnalysis(pandas meta-analysis, matplotlib remission rate plot) → researcher gets CSV of rates and visualized survival curves.
"Draft LaTeX review of EULAR imaging recommendations for Takayasu arteritis."
Synthesis Agent → gap detection(EULAR imaging papers) → Writing Agent → latexEditText(structured review) → latexSyncCitations(Dejaco 2018, Slart 2018) → latexCompile(PDF) → researcher gets compiled LaTeX manuscript with citations and figures.
"Find code for FDG-PET analysis in vasculitis imaging studies."
Research Agent → searchPapers('FDG-PET Takayasu code') → paperExtractUrls(Slart 2018) → paperFindGithubRepo → githubRepoInspect → researcher gets annotated GitHub repos with PET quantification scripts for vessel wall analysis.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ EULAR/ACR papers on Takayasu management, chaining searchPapers → citationGraph → GRADE grading for structured evidence report. DeepScan applies 7-step analysis with CoVe checkpoints to verify imaging protocol efficacy from Dejaco et al. (2018) against cohort outcomes. Theorizer generates hypotheses on anti-TNF response predictors from Hoffman et al. (2004) and Maz et al. (2021).
Frequently Asked Questions
What is the definition of Takayasu arteritis?
Takayasu arteritis is a granulomatous inflammation of the aorta and branches causing stenosis or aneurysms, mainly in young women (Özen et al., 2010).
What are key classification methods?
EULAR/PRINTO/PRES criteria (Özen et al., 2010; 1383 citations) and EULAR/PReS consensus (Özen et al., 2005; 831 citations) provide standardized pediatric classification.
What are pivotal papers?
Hellmich et al. (2019; 1098 citations) updates EULAR management; Dejaco et al. (2018; 941 citations) covers imaging; Maz et al. (2021; 564 citations) offers ACR guidelines.
What open problems exist?
Challenges include relapse prevention, optimal biologics, and imaging standardization for disease activity (Maksimowicz-McKinnon et al., 2007; Hoffman et al., 2004).
Research Vasculitis and related conditions with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Takayasu Arteritis with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Vasculitis and related conditions Research Guide